Cornerstone Robotics, a global leader in surgical robotics, has successfully raised more than US$70 million in its Series C funding round, led by EQT and joined by investors such as Qiming Venture Partners, Alpha JWC Ventures, the Innovation and Technology Venture Fund, eGarden Ventures, CTS Funds, K2VC, and Long-Z Capital. The funding will be used to accelerate the company’s commercialization efforts, including the development of new surgical robotic products, conducting clinical trials, securing regulatory approvals, and promoting the widespread adoption of its advanced robotic surgical technologies.
In addition to support from prominent investors, Cornerstone Robotics also received backing from the Innovation and Technology Venture Fund, under the Hong Kong Special Administrative Region Government’s Innovation and Technology Commission. This endorsement highlights the company’s innovation potential and its capability to expand its products globally. The funding will help the company further its expansion into key markets, including Europe and Southeast Asia.
Founded in 2019, Cornerstone Robotics is dedicated to making advanced surgical technologies more accessible worldwide. With a focus on in-house research and development and a vertically integrated supply chain, the company has been able to offer high-quality, cost-effective solutions, forging partnerships with leading medical centers across mainland China, Hong Kong, and Europe. Its successful clinical trials across various specialties, such as urology, general surgery, gynecology, and thoracic surgery, provide a strong foundation for future international growth.
Cornerstone Robotics achieved a key milestone in September 2024 with the approval of its “Sentire” Endoscopic Surgical System by the National Medical Products Administration (NMPA) in China. The company also expanded into the UK in the same year, further supporting its mission to deliver cutting-edge innovations and improve patient care across Europe and other global regions. Founder and CEO, Professor Samuel Au, expressed gratitude for the support received from shareholders, emphasizing the company’s ongoing commitment to innovation, global market expansion, and long-term development in the intelligent healthcare industry.
Cornerstone Robotics (CSR) is committed to making advanced surgical systems accessible, enabling patients worldwide to receive the highest quality of care. Our first-generation Endoscopic Surgical System, developed entirely in-house, has been approved by China’s National Medical Products Administration (NMPA). With state-of-the-art manufacturing facilities in the Greater Bay Area and a robust supply chain network, we provide safe, reliable, and accessible surgical robotic solutions to the global healthcare community.
